Quercetin Nanoparticle Ameliorates Lipopolysaccharide-Triggered Renal Inflammatory Impairment by Regulation of Sirt1/NF-KB Pathway.

Lu, Shan; Zhou, Shuai; Chen, Juwu; Zheng, Jian; Ren, Jia; Qi, Peiyi; Zhu, Zhiqiang; Li, Zhenzhen

Lu, Shan; Zhou, Shuai; Chen, Juwu; Zheng, Jian; Ren, Jia; Qi, Peiyi; Zhu, Zhiqiang; Li, Zhenzhen.

Afiliación

Lu S; Department of Emergency, The First Affiliated Hospital ofZhengzhou University, Zhengzhou 450052, PR China.
Zhou S; Department of Cardiology, The First Affiliated Hospital ofZhengzhou University, Zhengzhou 450052, PR China.
Chen J; Department of Emergency, The First Affiliated Hospital ofZhengzhou University, Zhengzhou 450052, PR China.
Zheng J; Department of Thyroid Surgery, The First Affiliated Hospital ofZhengzhou University, Zhengzhou 450052, PR China.
Ren J; Department of Emergency, The First Affiliated Hospital ofZhengzhou University, Zhengzhou 450052, PR China.
Qi P; Department of Emergency, The First Affiliated Hospital ofZhengzhou University, Zhengzhou 450052, PR China.
Zhu Z; Department of Emergency, The First Affiliated Hospital ofZhengzhou University, Zhengzhou 450052, PR China.
Li Z; Medical Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, PR China.

J Biomed Nanotechnol ; 17(2): 230-241, 2021 Feb 28.

Article en En | MEDLINE | ID: mdl-33785094

Asunto(s)

FN-kappa B; Nanopartículas; Animales; Humanos; Lipopolisacáridos/toxicidad; Ratones; Ratones Endogámicos C57BL; Quercetina/farmacología; Sirtuina 1

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: FN-kappa B / Nanopartículas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Biomed Nanotechnol Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google